Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Donor IFNL4 Genotype Is Associated with Transplant-Related Mortality after Unrelated Donor Myeloablative Hematopoietic Cell Transplantation in Patients with Acute Leukemia

Shahinaz M Gadalla, MDPhD, Tao Wang, BS, Olusegun Onabajo, PhD, Youjin Wang, Michael D. Haagenson, MS, Jennifer A. Sees, MPH, Stephen R. Spellman, Hormuzd A. Katki, PhD, Stephanie J. Lee, MD MPH, Ludmila Prokunina-Olsson, PhD

Blood (2018) 132 (Supplement 1): 968.

https://doi.org/10.1182/blood-2018-99-111391

Published: 2018

Journal Articles

Multiple Functional Donor Polymorphisms in IL1RL1 region Associate with Death Due to GvHD or Infection after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for AML and MDS

Blood (2018) 132 (Supplement 1): 312.

https://doi.org/10.1182/blood-2018-99-115276

Published: 2018

Journal Articles

Outcomes of Pediatric Patients with Acute Leukemia Following Adult Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching

Michael R Verneris, MD, Tao Wang, PhD, Stephen R. Spellman, Jennifer A. Sees, MPH, Michael D. Haagenson, MS, Sarah Cooley, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, Katharina Fleischhauer, Dean Anthony Lee, MD PhD, Sophie Paczesny, MD PhD, Hemalatha G. Rangarajan, MD, Jeffrey S. Miller, MD, Stephanie J. Lee, MD MPH

Blood (2018) 132 (Supplement 1): 4647.

https://doi.org/10.1182/blood-2018-99-116428

Published: 2018

Journal Articles

Impact of Human Leukocyte Antigen (HLA) Alleles on Outcomes of Allogeneic Transplantation (Allo-HCT) for B-Cell Non-Hodgkin Lymphomas (B-NHL); A CIBMTR Analysis

Basem M William, MD, Tao Wang, PhD, Michael D Haagenson, MS, Marcos J de Lima, MD, Marcelo Anibal Fernandez-Vina, PhD, Spellman Stephen, M.B.S., Stephanie J. Lee, MD, Brian T. Hill, MD PhD

Blood (2016) 128 (22): 3491.

https://doi.org/10.1182/blood.V128.22.3491.3491

Published: 2016

Journal Articles

Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

Shahinaz M. Gadalla, MD PhD MSC, Tao Wang, PhD, David Loftus, MD, Lyssa Friedman, RN, OCN, Casey Dagnall, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Ljubomir Buturovic, PhD, Marsha Blauwkamp, PhD, Jason Shelton, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Belynda Hicks, Kristine Jones, Stephanie J. Lee, MD, Sharon A Savage, MD FAAP

Blood (2016) 128 (22): 520.

https://doi.org/10.1182/blood.V128.22.520.520

Published: 2016

Journal Articles

Germline Mutations in Patients Receiving Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia

Shahinaz M. Gadalla, MD PhD MSC, Bari J Ballew, PhD, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Belynda Hicks, Blanche P Alter, MD MPH, Bin Zhu, PhD, Weiyin Zhou, MS, Meredith Yeager, PhD, Tao Wang, PhD, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Neal Freedman, PhD MPH, Stephanie J. Lee, MD, Sharon A Savage, MD FAAP

Blood (2016) 128 (22): 68.

https://doi.org/10.1182/blood.V128.22.68.68

Published: 2016

Journal Articles

Pilot Study of Prognostic Impact of Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Plasma Levels of CXC-Chemokines (CXCL-4 and CXCL-7) in Patients with Myelodysplastic Syndromes (MDS)

Binod Dhakal, MD MS, Tao Wang, PhD, Michael D Haagenson, MS, Fenlu Zhu, PhD, Carolyn A. Keever-Taylor, PhD, Stephen R. Spellman, MBS, Michael R. Verneris, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, MD, Stephanie J. Lee, MD, Wael Saber, MD MS

Blood (2016) 128 (22): 4678.

https://doi.org/10.1182/blood.V128.22.4678.4678

Published: 2016

Journal Articles

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

R. Coleman Lindsley, MD PhD, Wael Saber, MD MS, Brenton G. Mar, MD PhD, Robert A Redd, MS, Michael D Haagenson, MS, Peter V Grauman, BS, Stephen R. Spellman, MBS, Stephanie J. Lee, MD, Tao Wang, PhD, Michael R. Verneris, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, MD, Corey S. Cutler, MD MPH, Joseph H. Antin, MD, Donna S. Neuberg, ScD, Benjamin L. Ebert, MD PhD

Blood (2016) 128 (22): 69.

https://doi.org/10.1182/blood.V128.22.69.69

Published: 2016

Journal Articles

Investigating Effect of Genetic Admixture and Donor/Recipient Genetic Disparity on Transplant Outcomes

Abeer Madbouly, PhD, Tao Wang, PhD, Mark Albrecht, MSTAT, MBA, Vanja Paunic, PhD, Michael D Haagenson, MS, Cynthia Vierra-Green, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Navneet S. Majhail, MD MS, Stephanie J. Lee, MD MPH, Stephen R. Spellman, MBS, Martin Maiers, MS

Blood (2015) 126 (23): 3229.

https://doi.org/10.1182/blood.V126.23.3229.3229

Published: 2015

Journal Articles

Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR

Julia Pingel, PhD, Camila J. Hernandez Frederick, PhD, Tao Wang, PhD, Emmanuelle Polge, Michael D Haagenson, MS, Stephanie J. Lee, MD MPH, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc, Stephen R. Spellman, MBS, Alexander H. Schmidt, MD PhD, Jon J. van Rood, MD PhD

Blood (2015) 126 (23): 3226.

https://doi.org/10.1182/blood.V126.23.3226.3226

Published: 2015

Journal Articles

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Veronika Bachanova, MD, Daniel J. Weisdorf, MD, Tao Wang, PhD, Steven G.E. Marsh, PhD, Elizabeth Trachtenberg, PhD, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Guethlein A. Lisbeth, PhD, Martha Ladner, PhD, Peter Parham, PhD, Jeffrey S. Miller, MD, Sarah A. Cooley, MD MS

Blood (2014) 124 (21): 670.

https://doi.org/10.1182/blood.V124.21.670.670

Published: 2014

Journal Articles

Recipient HLA-C1 Enhances The Clinical Advantage Of Killer-Cell Immunoglobulin-Like Receptor B haplotype Donors In Myeloablative Unrelated Transplantation For Acute Myelogenous Leukemia

Sarah Cooley, MD, Daniel J. Weisdorf, MD, Lisbeth A Guethlein, John P Klein, PhD, Tao Wang, PhD, Steve G.E. Marsh, Stephen Spellman, MBS, Michael D Haagenson, MS, Koy Saeturn, Martha Ladner, Elizabeth Trachtenberg, Peter Parham, Jeffrey S. Miller, MD

Blood (2013) 122 (21): 549.

https://doi.org/10.1182/blood.V122.21.549.549

Published: 2013

Journal Articles

A Novel CD16xCD33 Bispecific Killer Cell Engager (BiKE) Mediates a Double Hit For Natural Killer (NK) Cells To Target CD33 + Myelodysplastic Syndrome (MDS) Cells and Myeloid Derived Suppressor Cells (MDSCs) At All Disease Stages

Michelle K. Gleason, PhD, Julie A. Ross, PhD, Troy C. Lund, MD/PhD, Michael R. Verneris, MD, Andres Wiernik, MD, Erica D. Warlick, MD, Stephen Spellman, MBS, Michael D. Haagenson, MS, Alexander J. Lenvik, Mark R. Litzow, MD, Daniel J. Weisdorf, MD, Daniel A. Vallera, PhD, Jeffrey S. Miller, MD

Blood (2013) 122 (21): 385.

https://doi.org/10.1182/blood.V122.21.385.385

Published: 2013

Journal Articles

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Single Nucleotide Polymorphisms Do Not Impact Outcomes After Unrelated Donor Transplant: A Center For International Blood and Marrow Transplant Research Analysis

Salyka Sengsayadeth, MD, Tao Wang, PhD, Stephanie J. Lee, MD, MPH, Michael D. Haagenson, MS, Stephen Spellman, MBS, Marcelo A. Fernandez Viña, PhD, D(ABHI), Carlheinz R. Muller, MD, PhD, Michael R. Verneris, MD, Bipin N. Savani, MD, Madan Jagasia, MBBS, MS

Blood (2013) 122 (21): 710.

https://doi.org/10.1182/blood.V122.21.710.710

Published: 2013

Journal Articles

Influence Of Killer Immunoglobulin-Like Receptor (KIR) and HLA Genotypes On Outcomes After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation For Patients With AML and MDS: A Report From The Center For International Blood and Marrow Transplant Research Immunobiology Working Committee

Ronald M. Sobecks, MD, Meighan M. Gallagher, BA, Medhat Askar, MD, PhD, Michael D. Haagenson, MS, Tao Wang, PhD, Stephen Spellman, MBS, Stephanie J. Lee, MD, MPH, Marcelo A. Fernandez Viña, PhD, D(ABHI), Carlheinz R. Muller, MD, PhD, Michael R. Verneris, MD, Ann E. Woolfrey, MD, Peter J. Shaw, MD, Daniel J. Weisdorf, MD, Sarah Cooley, MD, Jeffrey S. Miller, MD, Katharine C. Hsu, MD, PhD

Blood (2013) 122 (21): 159.

https://doi.org/10.1182/blood.V122.21.159.159

Published: 2013

Journal Articles

Identification of High Risk HLA Class I Amino Acid Substitutions in Hematopoietic Stem Cell Transplantation.

Susana R Marino, MD, PhD, Sang M Lee, PhD, T Andrew Binkowski, PhD, Michael D Haagenson, MS, Martin Maiers, PhD, Stephen Spellman, MBS, Koen van Besien, MD, Stephanie J Lee, MD, MPH, Theodore Karrison, PhD, Andrew Artz, MD MS

Blood (2012) 120 (21): 3050.

https://doi.org/10.1182/blood.V120.21.3050.3050

Published: 2012

Journal Articles

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Blood (2012) 120 (21): 467.

https://doi.org/10.1182/blood.V120.21.467.467

Published: 2012

Journal Articles

Donor KIR3DL1 and HLA-B Allotypes Control Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Fabio Giglio, MD, Ted A. Gooley, PhD, Jeffrey M Venstrom, MD, Meighan M Gallagher, LiHua Hou, PhD, Carolyn K Hurley, PhD, Tatiana Lebedeva, MD, PhD, Harriet Noreen, CHS, Raja Rajalingam, PhD, Elaine F Reed, PhD, Neng Yu, MD, Cynthia Vierra-Green, MS, Michael D Haagenson, MS, Mari Malkki, PhD, Effie W. Petersdorf, MD, Stephen Spellman, MBS, Katharine C. Hsu, MD, PhD

Blood (2012) 120 (21): 349.

https://doi.org/10.1182/blood.V120.21.349.349

Published: 2012

Journal Articles

Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR

Blood (2010) 116 (21): 897.

https://doi.org/10.1182/blood.V116.21.897.897

Published: 2010

Journal Articles

Health-Related Quality-of-Life Among Adult Matched Unrelated Stem Cell Donors: A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Randomized Trial of Marrow Versus PBSC Donation

Galen E. Switzer, PhD, Donna Harrington, BA, Michael D Haagenson, MS, Rebecca Drexler, BS, Amy Foley, MA, CCRP, Dennis L Confer, MD, Michelle Bishop, PhD, Paolo Anderlini, MD, Scott D Rowley, Susan Leitman, MD, Claudio Anasetti, MD, John R. Wingard, MD

Blood (2010) 116 (21): 366.

https://doi.org/10.1182/blood.V116.21.366.366

Published: 2010

NARROW

Donor IFNL4 Genotype Is Associated with Transplant-Related Mortality after Unrelated Donor Myeloablative Hematopoietic Cell Transplantation in Patients with Acute Leukemia

Multiple Functional Donor Polymorphisms in IL1RL1 region Associate with Death Due to GvHD or Infection after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for AML and MDS

Outcomes of Pediatric Patients with Acute Leukemia Following Adult Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching

Impact of Human Leukocyte Antigen (HLA) Alleles on Outcomes of Allogeneic Transplantation (Allo-HCT) for B-Cell Non-Hodgkin Lymphomas (B-NHL); A CIBMTR Analysis

Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

Germline Mutations in Patients Receiving Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia

Pilot Study of Prognostic Impact of Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Plasma Levels of CXC-Chemokines (CXCL-4 and CXCL-7) in Patients with Myelodysplastic Syndromes (MDS)

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Investigating Effect of Genetic Admixture and Donor/Recipient Genetic Disparity on Transplant Outcomes

Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Recipient HLA-C1 Enhances The Clinical Advantage Of Killer-Cell Immunoglobulin-Like Receptor B haplotype Donors In Myeloablative Unrelated Transplantation For Acute Myelogenous Leukemia

A Novel CD16xCD33 Bispecific Killer Cell Engager (BiKE) Mediates a Double Hit For Natural Killer (NK) Cells To Target CD33 + Myelodysplastic Syndrome (MDS) Cells and Myeloid Derived Suppressor Cells (MDSCs) At All Disease Stages

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Single Nucleotide Polymorphisms Do Not Impact Outcomes After Unrelated Donor Transplant: A Center For International Blood and Marrow Transplant Research Analysis

Identification of High Risk HLA Class I Amino Acid Substitutions in Hematopoietic Stem Cell Transplantation.

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Donor KIR3DL1 and HLA-B Allotypes Control Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR

Health-Related Quality-of-Life Among Adult Matched Unrelated Stem Cell Donors: A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Randomized Trial of Marrow Versus PBSC Donation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only